Viveve Medical Inc  

(Public, NASDAQ:VIVE)   Watch this stock  
Find more results for Patricia Bush´┐Ż
5.08
+0.05 (0.99%)
Jul 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.83 - 5.10
52 week 4.02 - 10.50
Open 5.04
Vol / Avg. 0.00/36,568.00
Mkt cap 51.49M
P/E     -
Div/yield     -
EPS -2.48
Shares 10.20M
Beta 0.03
Inst. own 58%

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -319.78% -858.74%
Operating margin -311.21% -828.61%
EBITD margin - -823.29%
Return on average assets -166.59% -185.39%
Return on average equity -753.39% -802.97%
Employees 21 -
CDP Score - -

Address

150 Commercial St
SUNNYVALE, CA 94086-5201
United States - Map
+1-408-5301900 (Phone)
+1-408-5301919 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Viveve Medical, Inc., formerly PLC Systems, Inc., designs, develops, manufactures and markets medical devices for the non-invasive treatment of vaginal laxity. The Company's Viveve Treatment is a non-invasive solution for vaginal laxity that is performed in approximately 30 minutes, in a physician's office. The Viveve System uses monopolar radiofrequency (RF) energy to generate low temperature heat. The vaginal mucosa is simultaneously cooled while this non-ablative heat is delivered into the submucosal layer. The RF energy stimulates the formation of collagen and causes the collagen fibers to remodel thereby tightening the submucosal tissue of the vaginal introitus. The RF stimulation causes subtle alterations in the collagen that can renew the tissue and further tighten the vaginal tissue over the next 1 to 3 months following treatment (the Viveve Treatment) and lead to increased sexual function.

Officers and directors

Brigitte H. Smith Chairman of the Board
Age: 47
Bio & Compensation  - Reuters
James G. Atkinson Chief Business Officer and President
Age: 57
Bio & Compensation  - Reuters
Patricia K. Scheller Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Scott C. Durbin Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Alan Curtis Vice President - Regulatory, Clinical and Quality
Bio & Compensation  - Reuters
Steve Lopez Director - Operations
Bio & Compensation  - Reuters
Lori H. Bush Director
Age: 59
Bio & Compensation  - Reuters
Debora A. Jorn Director
Bio & Compensation  - Reuters
Arlene M. Morris Director
Age: 64
Bio & Compensation  - Reuters
Jon M. Plexico Director
Age: 48
Bio & Compensation  - Reuters